{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:35:58Z","timestamp":1792892158588,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Innovation 2030 Major Projects","award":["2022ZD0211600"],"award-info":[{"award-number":["2022ZD0211600"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91849126"],"award-info":[{"award-number":["91849126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2018YFC1314700"],"award-info":[{"award-number":["2018YFC1314700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["No.2018SHZDZX01"],"award-info":[{"award-number":["No.2018SHZDZX01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Early prevention of Alzheimer\u2019s disease (AD) is a feasible way to delay AD onset and progression. Information on AD prediction at the individual patient level will be useful in AD prevention. In this study, we aim to develop risk models for predicting AD onset at individual level using optimal set of predictors from multiple features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 487 cognitively normal (CN) individuals and 796 mild cognitive impairment (MCI) patients were included from Alzheimer's Disease Neuroimaging Initiative. All the participants were assessed for clinical, cognitive, magnetic resonance imaging and cerebrospinal fluid (CSF) markers and followed for mean periods of 5.6\u00a0years for CN individuals and 4.6\u00a0years for MCI patients to ascertain progression from CN to incident prodromal stage of AD or from MCI to AD dementia. Least Absolute Shrinkage and Selection Operator Cox regression was applied for predictors selection and model construction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the follow-up periods, 139 CN participants had progressed to prodromal AD (CDR\u2009\u2265\u20090.5) and 321 MCI patients had progressed to AD dementia. In the prediction of individual risk of incident prodromal stage of AD in CN individuals, the AUC of the final CN model was 0.81 within 5\u00a0years. The final MCI model predicted individual risk of AD dementia in MCI patients with an AUC of 0.92 within 5\u00a0years. The models were also associated with longitudinal change of Mini-Mental State Examination (p\u2009&lt;\u20090.001 for CN and MCI models). An Alzheimer\u2019s continuum model was developed which could predict the Alzheimer\u2019s continuum for individuals with normal AD biomarkers within 3\u00a0years with high accuracy (AUC\u2009=\u20090.91).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The risk models were able to provide personalized risk for AD onset at each year after evaluation. The models may be useful for better prevention of AD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04646-x","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:02:23Z","timestamp":1698656543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multipredictor risk models for predicting individual risk of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiao-He","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Suckling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Tao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-0547","authenticated-orcid":false,"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"issue":"4","key":"4646_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","volume":"14","author":"J Jia","year":"2018","unstructured":"Jia J, et al. The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483\u201391.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"4646_CR2","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1111\/jgs.17345","volume":"69","author":"MP Aranda","year":"2021","unstructured":"Aranda MP, et al. Impact of dementia: health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc. 2021;69(7):1774\u201383.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"4646_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357\u201367.","journal-title":"Lancet Neurol"},{"issue":"4","key":"4646_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jalz.2016.06.2365","volume":"13","author":"M Mortamais","year":"2017","unstructured":"Mortamais M, et al. Detecting cognitive changes in preclinical Alzheimer\u2019s disease: a review of its feasibility. Alzheimers Dement. 2017;13(4):468\u201392.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"4646_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/17460441.2018.1457645","volume":"13","author":"R Cacabelos","year":"2018","unstructured":"Cacabelos R. Have there been improvements in Alzheimer\u2019s disease drug discovery over the past 5 years? Expert Opin Drug Discov. 2018;13(6):523\u201338.","journal-title":"Expert Opin Drug Discov"},{"key":"4646_CR6","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1046\/j.1532-5415.5153.x","volume":"51","author":"BP Leifer","year":"2003","unstructured":"Leifer BP. Early diagnosis of Alzheimer\u2019s disease: clinical and economic benefits. J Am Geriatr Soc. 2003;51:S281-8.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"4646_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2015.81","volume":"11","author":"A Solomon","year":"2015","unstructured":"Solomon A, Soininen H. Dementia: risk prediction models in dementia prevention. Nat Rev Neurol. 2015;11(7):375\u20137.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"4646_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S1474-4422(16)30235-6","volume":"15","author":"H Shah","year":"2016","unstructured":"Shah H, et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 2016;15(12):1285\u201394.","journal-title":"Lancet Neurol"},{"issue":"4","key":"4646_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/jnnp-2018-318212","volume":"90","author":"XH Hou","year":"2019","unstructured":"Hou XH, et al. Models for predicting risk of dementia: a systematic review. J Neurol Neurosurg Psychiatry. 2019;90(4):373\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"4646_CR10","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jamaneurol.2017.2712","volume":"74","author":"IS van Maurik","year":"2017","unstructured":"van Maurik IS, et al. Interpreting biomarker results in individual patients with mild cognitive impairment in the Alzheimer\u2019s biomarkers in daily practice (ABIDE) project. JAMA Neurol. 2017;74(12):1481\u201391.","journal-title":"JAMA Neurol"},{"issue":"1","key":"4646_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13195-019-0487-y","volume":"11","author":"IS van Maurik","year":"2019","unstructured":"van Maurik IS, et al. Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project. Alzheimers Res Ther. 2019;11(1):33.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"4646_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrneurol.2010.54","volume":"6","author":"BC Stephan","year":"2010","unstructured":"Stephan BC, et al. Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol. 2010;6(6):318\u201326.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"4646_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"4646_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, et al. Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol. 2009;65(4):403\u201313.","journal-title":"Ann Neurol"},{"issue":"3","key":"4646_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","volume":"75","author":"SM Landau","year":"2010","unstructured":"Landau SM, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010;75(3):230\u20138.","journal-title":"Neurology"},{"issue":"4","key":"4646_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr, et al. The Alzheimer\u2019s disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008;27(4):685\u201391.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"4646_CR17","doi-asserted-by":"publisher","first-page":"e1002258","DOI":"10.1371\/journal.pmed.1002258","volume":"14","author":"RS Desikan","year":"2017","unstructured":"Desikan RS, et al. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. PLoS Med. 2017;14(3):e1002258.","journal-title":"PLoS Med"},{"issue":"9","key":"4646_CR18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","volume":"15","author":"JT Yu","year":"2019","unstructured":"Yu JT, et al. Frequency and longitudinal clinical outcomes of Alzheimer\u2019s AT(N) biomarker profiles: a longitudinal study. Alzheimers Dement. 2019;15(9):1208\u201317.","journal-title":"Alzheimers Dement"},{"issue":"30","key":"4646_CR19","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397.","journal-title":"Stat Med"},{"issue":"11","key":"4646_CR20","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S1474-4422(19)30283-2","volume":"18","author":"IS van Maurik","year":"2019","unstructured":"van Maurik IS, et al. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurol. 2019;18(11):1034\u201344.","journal-title":"Lancet Neurol"},{"issue":"6","key":"4646_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jalz.2013.11.006","volume":"10","author":"DE Barnes","year":"2014","unstructured":"Barnes DE, et al. Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement. 2014;10(6):656\u201365.","journal-title":"Alzheimers Dement"},{"key":"4646_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12916-016-0549-y","volume":"14","author":"K Walters","year":"2016","unstructured":"Walters K, et al. Predicting dementia risk in primary care: development and validation of the dementia risk score using routinely collected data. BMC Med. 2016;14:6.","journal-title":"BMC Med"},{"issue":"2","key":"4646_CR23","doi-asserted-by":"publisher","first-page":"e16852","DOI":"10.1371\/journal.pone.0016852","volume":"6","author":"F Jessen","year":"2011","unstructured":"Jessen F, et al. Prediction of dementia in primary care patients. PLoS ONE. 2011;6(2):e16852.","journal-title":"PLoS ONE"},{"issue":"6","key":"4646_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jalz.2013.11.009","volume":"10","author":"JJ Gomar","year":"2014","unstructured":"Gomar JJ, Conejero-Goldberg C, Davies P, Goldberg TE. Extension and refinement of the predictive value of different classes of markers in ADNI: Four-year follow-up data. Alzheimers Dement. 2014;10(6):704\u201312.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"4646_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/jamaneurol.2015.3135","volume":"73","author":"B Lehallier","year":"2016","unstructured":"Lehallier B, et al. Combined plasma and cerebrospinal fluid signature for the prediction of midterm progression from mild cognitive impairment to Alzheimer disease. JAMA Neurol. 2016;73(2):203\u201312.","journal-title":"JAMA Neurol"},{"key":"4646_CR26","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605.","journal-title":"BMJ"},{"issue":"5","key":"4646_CR27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jalz.2013.05.1772","volume":"10","author":"LG Exalto","year":"2014","unstructured":"Exalto LG, et al. Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement. 2014;10(5):562\u201370.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"4646_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S2213-8587(13)70048-2","volume":"1","author":"LG Exalto","year":"2013","unstructured":"Exalto LG, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013;1(3):183\u201390.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"4646_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5(9):735\u201341.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4646_CR30","doi-asserted-by":"publisher","first-page":"e86141","DOI":"10.1371\/journal.pone.0086141","volume":"9","author":"KJ Anstey","year":"2014","unstructured":"Anstey KJ, et al. A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI. PLoS ONE. 2014;9(1):e86141.","journal-title":"PLoS ONE"},{"issue":"6","key":"4646_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484\u201396.","journal-title":"Lancet Neurol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04646-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:02:41Z","timestamp":1698656561000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04646-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4646"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04646-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by institutional review boards of all participating institutions, and written informed consent was obtained from all participants or their guardians according to the Declaration of Helsinki (consent for research).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"768"}}